Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2008-09-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who
have previously untreated or relapsed mantle cell lymphoma.